Botulinum Toxin Injection of the Cricopharyngeus Muscle for the Treatment of Dysphagia

Abstract

OBJECTIVE: This study was conducted to evaluate, subjectively and objectively, the diagnostic and therapeutic effects of botulinum toxin (Botox) in patients with dysphagia caused by cricopharyngeus (CP) muscle spasm and/or hypertonicity.

METHODS: A retrospective chart review was done of 5 patients with normally functioning larynges treated with CP Botox injection for dysphagia caused by perceived spasm. Subjective measures of swallowing function after injection were obtained with a patient questionnaire. Objective data were obtained both before and after surgery by one or more of the following tests: modified barium swallow study, manometry, videostroboscopy, and fiberoptic endoscopic evaluation of swallowing. Quality-of-life measures were obtained with a swallowing rating scale.

RESULTS: Overall, all patients had initial improvement in swallowing after Botox injection. The duration of benefit was from 2 to 14 months. There were no complications. Four of 5 patients had long-term benefits, as evidenced by decreased or eliminated aspiration symptoms, removal of tracheotomy, ability to eat solid foods, and weight gain. One patient continues to have poor swallowing function.

CONCLUSION: Botox injection of the CP muscle to treat dysphagia is effective in patients with underlying muscle spasm or hypertonicity. A positive response to Botox can also help confirm the diagnosis of CP muscle spasm.

Get full access to this article

View all access options for this article.

References

Jankovic

Brin

. Therapeutic use of botulinum toxin. N Engl J Med 1991; 324:1186–92.

Blitzer

Komisar

Baredes

, et al. Voice failure after tracheoesophageal puncture. Management with botulinum toxin. Otolaryngol Head Neck Surg 1995;113:668–71.

Crary

Glowasky

. Using botulinum toxin A to improve speech and swallowing function following total laryngectomy. Arch Otolaryngol Head Neck Surg 1996;122:760–3.

Dufour

Fawaz

Libby

. Botulinum toxin injection for secondary achalasia with esophageal varices. Gastrointest Endosc 1997;45:191–3.

Blitzer

Brin

. Laryngeal dystonia: A series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 1991;100:85–9.

DeVault

. Dysphagia from esophageal diverticulosis responding to botulinum toxin injection. Am J Gastroenterol 1997;92:895–7.

Blitzer

Brin

. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg 1997;116:328–9.

Blitzer

. Cricopharyngeal muscle spasm and dysphagia. Op Tech Otolaryngol Head Neck Surg 1997;8:191–2.

Schneider

Thumfart

Pototschnig

, et al. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin with introduction of a new non-invasive method. Ann Otol Rhinol Laryngol 1994;103:31–5.

10.

Lund

. The function of the cricopharyngeal sphincter during swallowing. Acta Otolaryngol 1965;59:497–510.

11.

McKenna

Dedo

. Cricopharyngeal myotomy: Indications and technique. Ann Otol Rhinol Laryngol 1992;101:216–21.

12.

St. Guily

Perie

Willig

. Swallowing disorders in muscular disease: Functional assessment and indication of cricopharyngeal myotomy. Ear Nose Throat J 1994;73:34–40.

13.

Broniatowski

Sonies

Rubin

, et al. Current evaluation and treatment of patients with swallowing disorders. Otolaryngol Head Neck Surg 1999;120:464–74.

14.

Hembree

. Dysphagia evaluation and treatment. Op Tech Otolaryngol Head Neck Surg 1997;8:185–90.

15.

Langmore

Schatz

Olson

. Endoscopic and videofluoroscopic evaluation of swallowing and aspiration. Ann Otol Rhinol Laryngol 1991;100:678–81.

16.

Langmore

Schatz

Olson

. Fiberoptic endoscopic examination of swallowing safety: A new procedure. Dysphagia 1988; 2:216–9.

17.

Kelly

. Use of manometry in the evaluation of dysphagia. Otolaryngol Head Neck Surg 1997;116:355–7.